Companies / California / Qualigen Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Qualigen Therapeutics? Who to reach and why now

Headquartered in El Segundo, California, Qualigen Therapeutics is a publicly listed finance services company. It raised $4.5M in Jul 2025 and its filings name 7 officers. Everything below links to the record it came from.

Listed company · Finance Services · California

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerCampbell BecherSEC filing, Jul 2025Named officer in the filing; part of the buying group
Chief Technology OfficerKevin Richardson IISEC filing, Jul 2025Technology and tooling decisions
Chief Technology OfficerBraeden LichtiSEC filing, Jul 2025Technology and tooling decisions
Chief Technology OfficerRobert B. LimSEC filing, Jul 2025Technology and tooling decisions
Chief Technology OfficerCody PriceSEC filing, Jul 2025Technology and tooling decisions
Chief Technology OfficerRobert LimSEC filing, Nov 2024Technology and tooling decisions
Chief Technology OfficerGraydon BenslerSEC filing, Nov 2024Technology and tooling decisions
For sellersWhy Qualigen Therapeutics is worth a call this quarterBuy Window: open · major agreement Oct 2026
Oct 2026Oct 2026

Corporate event

Signed a material agreement

Corporate event
Oct 23Oct 2026

New leadership

Officer or director change

New leadership
Jul 2026Jul 2026

Capital

Filed to go public

Capital
Track Qualigen Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Qualigen Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 23, 2026Signed a material agreementCorporate eventSEC filing
Oct 23, 2026Completed an acquisition or saleCorporate eventSEC filing
Oct 23, 2026Officer or director changeNew leadershipSEC filing
Oct 14, 2026Signed a material agreementCorporate eventSEC filing
Aug 21, 2026Officer or director changeNew leadershipSEC filing
Jul 29, 2026Signed a material agreementCorporate eventSEC filing
Jul 27, 2026Filed to go publicCapitalSEC filing
Jul 28, 2025Raised $4.5M in equity from 14 investorsCapitalSEC filing

Reach Qualigen Therapeutics with emails that land

Lakewave finds the right people at Qualigen Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Qualigen Therapeutics with a free trial →

About Qualigen Therapeutics

HeadquartersEl Segundo, California, per the filing address
Industry groupFinance Services
OwnershipListed company
Raise history$5.1M (Nov 2024) · $4.5M (Jul 2025)
Lakewave Rising52 · 3 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Dave · 18Upstart · 6Chime FinancialOportun FinancialSofi TechnologiesSee all 5 with a free trial →

Questions people ask

Did Qualigen Therapeutics raise funding in 2025?

Yes. Qualigen Therapeutics reported a $4.5M equity raise to the SEC on Jul 28, 2025 with 14 investors.

Who runs Qualigen Therapeutics?

The company's SEC filing, Jul 2025 names Campbell Becher (Executive Officer) among its officers.

Where is Qualigen Therapeutics headquartered?

El Segundo, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.